SYNLAB (HMSE:SYAB) - Stock Price, News & Analysis

SYAB Stock Overview

Provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. More details

SYAB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Became profitable this year

Risk Analysis

Earnings are forecast to decline by an average of 11.4% per year for the next 3 years

Large one-off items impacting financial results

SYNLAB AG Competitors

Fresenius Medical Care

XTRA:FME

€12.0b

RHÖN-KLINIKUM

XTRA:RHK

€843.4m

Carl Zeiss Meditec

XTRA:AFX

€5.1b

Nexus

XTRA:NXU

€1.2b

Price History & Performance

Summary of all time highs, changes and price drops for SYNLAB
Historical stock prices
Current Share Price	€11.46
52 Week High	€11.70
52 Week Low	€10.66
Beta	0.89
11 Month Change	4.18%
3 Month Change	3.80%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	3.99%

Recent updates

Shareholder Returns

	SYAB	DE Healthcare	DE Market
7D	-0.3%	-0.3%	-0.4%
1Y	n/a	14.5%	7.1%

Return vs Industry: Insufficient data to determine how SYAB performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how SYAB performed against the German Market.

Price Volatility

Is SYAB's price volatile compared to industry and market?
SYAB volatility
SYAB Average Weekly Movement	2.4%
Healthcare Industry Average Movement	4.1%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.0%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: SYAB has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine SYAB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1998	27,000	Mathieu Floreani	www.synlab.com

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

SYNLAB AG Fundamentals Summary

How do SYNLAB's earnings and revenue compare to its market cap?
SYAB fundamental statistics
Market cap	€2.51b
Earnings (TTM)	€89.35m
Revenue (TTM)	€2.62b

28.2x

P/E Ratio

1.0x

P/S Ratio

Is SYAB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SYAB income statement (TTM)
Revenue	€2.62b
Cost of Revenue	€604.92m
Gross Profit	€2.01b
Other Expenses	€1.92b
Earnings	€89.35m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.41
Gross Margin	76.87%
Net Profit Margin	3.42%
Debt/Equity Ratio	39.0%

How did SYAB perform over the long term?

See historical performance and comparison

SYNLAB HMSE:SYAB Stock Report